← All companies

ETRA

Electra Therapeutics, Inc.

ETRA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$8.10

-0.54 -6.25%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$7.95 – $15.50

Recent SEC filings

34 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Other events Sep 21, 2026

Other filings

SCHEDULE 13G Oct 29, 2026

SCHEDULE 13G Sep 28, 2026

SCHEDULE 13G Sep 28, 2026

SCHEDULE 13D Sep 25, 2026

3 OWNERSHIP DOCUMENT Sep 21, 2026

S-8 Sep 21, 2026

424B4 Sep 18, 2026

CERT Sep 18, 2026

8-A12B Sep 18, 2026

EFFECT Sep 17, 2026

S-1MEF Sep 17, 2026

S-1/A Sep 14, 2026

S-1 Aug 28, 2026

DRS/A Aug 10, 2026

DRS Jun 26, 2026

D Item 06b Oct 30, 2025